M&A / Deals UCB and Cancer Research UK form expanded alliance to advance novel cancer therapies PharmaTimesPartnership builds on existing collaboration and adds two new UCBnominated projectsOncologyRead full story pharminent May 7, 2026 (Last updated: May 8, 2026) PharmaTimes Partnership builds on existing collaboration and adds two new UCBnominated projects Oncology Read full story Post navigation Previous: Eli Lilly pledges $4.5bn to bolster Indiana-based manufacturingNext: Roche buys AI-powered diagnostics player PathAI Related Stories M&A / Deals BioMarin spends up to $490m for Alesta’s bone disease candidate pharminent August 19, 2026 M&A / Deals J&J hands lymphoma bispecific CAR T back to AbelZeta pharminent August 17, 2026 M&A / Deals Novo Nordisk and AWS form AI partnership to speed drug discovery pharminent August 17, 2026
